The primary purpose of On-X Life Technologies Inc.´s Heart Valve Product Group is to produce the innovative On-X Prosthetic Heart Valve and additional heart valve technologies the company will be developing.
The On-X Prosthetic Heart Valve is a pure carbon bileaflet heart valve prosthesis, developed at On-X Life Technologies, Inc., by the world’s most experienced mechanical heart valve designers.
The exceptional clinical success of the On-X valve results from numerous innovations that distinguish it from all other prosthetic heart valves. The design maximizes benefit for the recipient and mitigates many of the problems associated with valve prostheses.
On-X Ascending Aortic Prosthesis with the
Vascutek Gelweave Valsalva Graft
NEW!! In January of 2011, the FDA approved the only valve/graft combination.
Click here for further information about the On-X® Ascending Aortic Prosthesis with the Vascutek Gelweave Valsalva™ Graft.
PROACT Study
In January of 2006, the FDA approved the first and only IDE (Investigational Device Exemption) lowered anticoagulation trial for a mechanical valve to be conducted at 40 sites in the United States for the On-X Prosthetic Heart Valve.
Click here for further information about the PROACT study.
